• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Quantitative analysis on mechanisms of growth inhibition with cancer of the genito-urinary system in vivo and in vitro.

Research Project

Project/Area Number 59440068
Research Category

Grant-in-Aid for General Scientific Research (A)

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionSchool of Medicine Keio University

Principal Investigator

TAZAKI Hiroshi  School of Medicine Keio University, 医学部, 教授 (90051268)

Co-Investigator(Kenkyū-buntansha) NAKAMURA Kaoru  School of Medicine Keio University, 医学部, 助手 (10146673)
DEGUCHI Nobuhiro  School of Medicine Keio University, 医学部, 講師 (90118977)
BABA Shiro  School of Medicine Keio University, 医学部, 講師 (00051889)
JITSUKAWA Seido  School of Medicine Keio University, 医学部, 助教授 (00101957)
Project Period (FY) 1984 – 1986
Project Status Completed (Fiscal Year 1986)
Budget Amount *help
¥11,000,000 (Direct Cost: ¥11,000,000)
Fiscal Year 1986: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1985: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 1984: ¥8,500,000 (Direct Cost: ¥8,500,000)
KeywordsCancer of the genito-urinary system / Growth inhibition / Monoclonal antibodies / Interferon / Tumor Necrosis Factor / BCG / Tumor necrosis factor / 膀胱癌 / 腎癌 / モノクロナール抗体
Research Abstract

TBSN-2, a monoclonal antibody derived from a cultured cell line of bladder origin, KU-1, showed high cytotoxicity against cultured cell-lines derived from bladder tumors and fresh surgical specimens of bladder tumors as well. Also noted was increased cytotoxicity by the monoclonal antibody in the presence of compliments (Sasaki, Keio J. Med. 33, 1984). ARC-1, a monoclonal antibody derived from a cultured cell-line of renal origin, KU-2, showed cytotoxicity against different tumor cells of different renal tumors. The heterogeneity regarding immunological characteristics was shown to be present in different clones of KU-2 (Nakamura, Keio J. Med. 35, 1986). Various interferons ( <alpha> , <beta> , <gamma> )had an inhibitory effect upon growth of cultured cell of renal and prostatic tumor origin, and NK activity was thought to contribute to the inhibitory effect (Marumo, Keio J. Med. 33, 1984). Furthermore, tumoricidal effect by these interferons was shown to increase by preincubation of t … More he effector cells, and recycling of NK cells was suggested (Marumo, Keio J. Med. 33, 1984). Another known immunopotentiator, BCG, was shown to exhibit both cytolytic and cytostatic effect upon ulture cells of bladder origin mediated by macrophages (Nakamura, Keio J. Med. 33, 1984). Assessment of an immunological profile determined by quantification of serum cytokines showed an increased-level of TNF in patients with renal cell and prostatic tumors (Nakajima, Jap. Canc. So. 1986). When the correlation between biological grades of tumors and intranuclear DNA contents of these tumors was examined, undifferentiated tumors showed marked abnormality in this regard. Therefore determination of DNA-contents was thought to be useful to predict the growth or metastatic potential of tumors (Tachibana, Jap. J. Urology, 77, 1986). These results indicated that factors related to the environment in cancer-bearing host could be a determinant in the proliferation of tumors, and also because of the presence of clonal heterogeity existing in a given tumor. Less

Report

(2 results)
  • 1986 Final Research Report Summary
  • 1985 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Mitsunobu Sasaki: Keio J.Med.33. 39-56 (1984)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Kaoru Nakamura: Keio J.Med.33. 185-199 (1984)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Ken Marumo: Keio J.Med.33. 201-209 (1984)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] 丸茂健: 日本泌尿器科学会雑誌. 76. 965-973 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] 橘政昭: 日本泌尿器科学雑誌. 77. 1851-1856 (1986)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] 橘政昭: 日本泌尿器科学会雑誌. 77. 1857-1863 (1986)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] 橘政昭: 日本泌尿器科学会雑誌. 77. 1864-1867 (1986)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] So Nakamura: Keio J.Med.35. 276-290 (1986)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Seido Jitsukawa: Urology. 24. 218-222 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Mitsunobu Sasaki: "Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines." Keio J. Med.33. 39-56 (1984)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Kaoru Nakamura: "Monocyte-mediated cytotoxity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus Calmette-Guerin." Keio J. Med.33. 185-199 (1984)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Ken Marumo et, al.: "Immunological study of anti-cancer effects of human alpha interferon for advanced renal cell carcinoma." Jap. J. Urology. 76. 965-973 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Ken Marumo et. al.: "Mechanism of augmentation of natural cytotoxicity by human beta-interferon." Keio J. Med.33. 201-209 (1984)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Masaaki Tachibana et. al.: "Clinical application of flow-cytometry in urology. 1. Classification of human bladder carcinomas using flow cytometry." Jap. J. Urology. 77. 1851-1856 (1986)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Masaaki Tachibana et. al.: "Clinical application of flow cytometry in urology. 2. Comparison between bladder biopsy specimens and bladder irrigation samples by flow cytometric DNA-histogram." Jap. J. Urology. 77. 1857-1863 (1986)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Masaaki Tachibana et. al.: "Clinical application of flow cytometry in urology. 3. Correlation between urinary cytology and flow cytometry." Jap. J. Urology. 77. 1864-1867 (1986)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] So Nakamura: "Antigenic heterogeneity of long-term cultured renal carcinoma cell line (KU-2) analyzed by tumor specific monoclonal antibodies." Keio J. Med.35. 276-290 (1986)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Seido Jitsukawa: "Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor." Urology. 24. 218-222 (1987)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Keio J.med.3.

    • Related Report
      1985 Annual Research Report

URL: 

Published: 1987-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi